Soluble Urokinase Receptor and Chronic Kidney Disease

BACKGROUND: Relatively high plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) have been associated with focal segmental glomerulosclerosis and poor clinical outcomes in patients with various conditions. It is unknown whether elevated suPAR levels in patients with normal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Hayek, Salim S., Sever, Sanja, Ko, Yi-An, Trachtman, Howard, Awad, Mosaab, Wadhwani, Shikha, Altintas, Mehmet M., Wei, Changli, Hotton, Anna L., French, Audrey L., Sperling, Laurence S., Lerakis, Stamatios, Quyyumi, Arshed A., Reiser, Jochen
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4701036/
https://ncbi.nlm.nih.gov/pubmed/26539835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1506362
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados